Vitamin E/Cambridge Heart Antioxidant Study: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: {| class="wikitable" align="right" |+ Cambridge Heart Antioxidant Study (CHAOS)<ref name="pmid8622332">{{cite journal |author=Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mi...) |
imported>Caesar Schinas m (Template:Vitamin E/Cambridge Heart Antioxidant Study moved to Vitamin E/Cambridge Heart Antioxidant Study over redirect) |
| (One intermediate revision by one other user not shown) | |
(No difference)
| |
Latest revision as of 00:41, 23 May 2009
| Nonfatal MI | |
|---|---|
| Vitamin E 800 IU/day | 2.0% (11/546) |
| Vitamin E 400 IU/day | 0.6% (3/489) |
| Placebo | 4.2% (41/967) |
- ↑ Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (March 1996). "Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)". Lancet 347 (9004): 781–6. DOI:10.1016/S0140-6736(96)90866-1. PMID 8622332. Research Blogging.